HEPION PHARMACEUTICALS, INC. Public Float
HEPION PHARMACEUTICALS, INC. (HEPA) had Public Float of $900.00 thousand as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $900.00K.
- 2024-06-30: Entity Public Float $5.90M.
- 2023-06-30: Entity Public Float $40.30M.
- 2022-06-30: Entity Public Float $43.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $900.00K 10-K · filed 2026-03-12 |
| 2024-06-30 | $5.90M 10-K · filed 2025-04-08 |
| 2023-06-30 | $40.30M 10-K/A · filed 2025-01-13 |
| 2022-06-30 | $43.40M 10-K · filed 2023-04-10 |
| 2021-06-30 | $150.80M 10-K · filed 2022-04-08 |
| 2020-06-30 | $25.60M 10-K · filed 2021-03-31 |
| 2019-06-30 | $14.40M 10-K · filed 2020-05-14 |
| 2018-06-30 | $13.90M 10-K · filed 2019-03-14 |
| 2017-06-30 | $43.90M 10-KT · filed 2018-03-26 |
| 2016-12-31 | $70.00M 10-K · filed 2017-09-28 |
| 2015-12-31 | $41.94M 10-K · filed 2016-09-28 |
| 2014-12-31 | $49.37M 10-K · filed 2015-09-25 |
| 2013-12-31 | $0.00 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |